TMO
40
-3
MTB
49
-14
ES
28
4
ZTS
9
-7
AVGO
13
-2
STX
45
-3
TGNA
66
-3
EMN
42
-3
AME
47
-4
WYNN
30
-6
SHW
49
-3
SWK
28
-6
BBY
43
-3
COST
38
-3
DE
53
-7
GWW
51
-9
CCL
47
-7
VRSN
53
-4
CINF
51
-3
MDLZ
67
-2
TMO
40
-3
MTB
49
-14
ES
28
4
ZTS
9
-7
AVGO
13
-2
STX
45
-3
TGNA
66
-3
EMN
42
-3
AME
47
-4
WYNN
30
-6
SHW
49
-3
SWK
28
-6
BBY
43
-3
COST
38
-3
DE
53
-7
GWW
51
-9
CCL
47
-7
VRSN
53
-4
CINF
51
-3
MDLZ
67
-2
Financhill
Back

Capricor Therapeutics Stock Predictions

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33

CAPR
Capricor Therapeutics

Last Price:
$11.50
Seasonality Move:
-8.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Capricor Therapeutics Stock Forecast

  • Over the next 52 weeks, Capricor Therapeutics has on average historically fallen by 1.8% based on the past 18 years of stock performance.
  • Capricor Therapeutics has fallen lower in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Capricor Therapeutics Stock Undervalued?
    The current Capricor Therapeutics [CAPR] share price is $11.50. The Score for CAPR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • CAPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Capricor Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Capricor Therapeutics has on average historically fallen by 1.8% based on the past 18 years of stock performance.

Capricor Therapeutics Stock Rating

Sell
33
Capricor Therapeutics (CAPR) is a Sell

Is Capricor Therapeutics overpriced?

  • Capricor Therapeutics has fallen lower in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Capricor Therapeutics Stock Price History

Is CAPR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAPR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
capricor.com

52-Week Data

52-Week High:
23.40
52-Week Low:
3.52

Prediction Charts

Market Cap:
525.3M
Price in USD:
11.50
Volume:
1.2M
Beta:
1.16

Technical Analysis

SMA50:
13.94
SMA100:
15.10
SMA200:
11.48
52-Wk Change:
69.37%

Stock Predictions

  • Is Capricor Therapeutics stock public?
    Yes, Capricor Therapeutics is a publicly traded company.
  • What is the Capricor Therapeutics stock quote today?
    The Capricor Therapeutics stock price is 11.50 USD today.
  • How to buy Capricor Therapeutics stock online?
    You can buy Capricor Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-11 12.34 12.57 13.14 11.75
Mar-12 12.93 13.07 13.34 12.55
Mar-13 13.08 12.79 13.42 12.67
Mar-14 13.00 13.23 13.40 12.80
Mar-17 13.32 12.88 13.92 12.68
Mar-18 12.88 11.61 12.94 11.55
Mar-19 11.76 12.22 12.38 11.60
Mar-20 12.56 14.36 14.75 12.23
Mar-21 14.16 12.86 14.16 12.75
Mar-24 13.13 13.28 13.32 12.64
Mar-25 13.20 13.48 13.68 12.86
Mar-26 13.28 13.18 13.58 12.81
Mar-27 13.33 11.82 13.81 11.81
Mar-28 11.79 11.50 11.85 11.04

Capricor Therapeutics Earnings

Capricor Therapeutics Earnings Report: Per Share Capricor Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Capricor Therapeutics Forecast Revenue Growth

Capricor Therapeutics Stock Analysis: Historical quarterly revenues per share for Capricor Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.65 per share, an increase this year of $0.82 per share, and an increase next year of $0.18 per share.

* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.